Chronic pain: Switching to an alternate opioid analgesic

Canadian Pharmaceutical Journal

Volumn 138, Issue 1, 2005, Pages 44-45

  Ruddock, Brent ^a  

^a Ontario Pharmacists' Association Drug Information and Research Centre   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CODEINE; FENTANYL; HYDROMORPHONE; METHADONE; MORPHINE; NARCOTIC ANALGESIC AGENT; OXYCODONE; PERCOCET; PETHIDINE;

ADULT; ANALGESIA; BIOEQUIVALENCE; CARDIOPULMONARY INSUFFICIENCY; CASE REPORT; CHRONIC PAIN; COMORBIDITY; DOSE CALCULATION; DRUG CROSS TOLERANCE; DRUG SAFETY; DRUG SUBSTITUTION; ENVIRONMENTAL FACTOR; FATIGUE; FEMALE; HUMAN; INDIVIDUALIZATION; KIDNEY DISEASE; LOW BACK PAIN; NAUSEA; NEUROTOXICITY; PHARMACIST; QUALITY OF LIFE; SHORT SURVEY;

EID: 26244439482     PISSN: 08286914     EISSN: None     Source Type: Journal    
DOI: 10.1177/171516350513800108     Document Type: Short Survey

References (5)

1. Gammaitoni AR, Fine P, Alvarez N, McPherson ML, Bergmark S. Clinical application of opioid equianalgesic data. Clin J Pain 2003;19(5):286-97.
2. Pereira J, Lawlor P, Vigano A, Dorgan M, Bruera E. Equianalgesic dose ratios for opioids: a critical review and proposals for long-term dosing. J Pain Symptom Manage 2001;22(2):672-87.
3. Anderson R, Saiers JH, Abram S, Schlicht C. Accuracy in equianalgesic dosing. Conversion dilemmas. J Pain Symptom Manage 2001;21(5):397-406.
4. Indelicate RA, Portenoy RK. Opioid rotation in the management of refractory cancer pain. J Clin Oncol 2002;20(1):348-52.
5. Gardner-Nix J. Principles of opioid use in chronic noncancer pain. CMAJ 2003;169 (1):38-43.